6-Hour Virtual Seminar

6-Hour Virtual Seminar on Medical Device Single Audit Program [MDSAP] Implementation & Participating Country Regulatory Processes: U.S., Canada, Brazil, Australia and Japan

Product Id : 10018
Robert J. Russell

Price Details

US$595.00 Recorded
US$945.00 Corporate Recorded
Price Details  + Refund Policy

Global Medical Device Regulations continue to evolve, as devices become more diverse and sophisticated. Understanding the regulations and requirements in your targeted markets will expedite speed-to-market of innovative products and assist patients needing access to life-saving  products and technologies. Government Regulatory Authorities, needing to become more efficient with their time, are looking for ways to better use their internal resources without compromising safety in products, which become marketable.

One such example is the Medical Device Single Audit Program [MDSAP], where Authorized Organizations would be allowed to carry out a single GMP audit on medical device manufacturing facilities and have it stand to support registrations across the current participating member countries: U.S. Canada, Brazil, Australia and Japan. Health Canada has now made the MDSAP process mandatory for all licensed products in Canada.

Why you should attend

This 6 hrs. webinar is focused on understanding the Medical Device Single Audit Program, the scope of the program, how to apply, the Authorized Organizations, the rating system developed and what you can expect when signing onto the program. The webinar will discuss how such audits are organized, what to expect during a MDSAP audit, how does this differ from a typical certified body audit, along with document movement and timeline expectations in receiving the facility’s certificate.

Highlights of the key Regulatory Requirements for Medical Devices will also be covered for the participating MDSAP Countries of: U.S., Canada, Brazil, Australia and Japan.

Learning Objectives:

  • The Medical Device Single Audit Program (MDSAP)
  • Device Classification
  • Licensing Pathways
  • Medical Device GMP
  • Inspections
  • Device Labeling
  • License Holder Responsibilities
  • Timelines and Fees
  • Country Specific Cultural Considerations and Challenges
  • Adverse Event Reporting

Who Will Benefit

  • Regulatory Affairs
  • Quality Assurance, Quality control, and Quality systems
  • Product Development Personnel
  • Contract Research Organizations
  • Business Management
  • Site Managers
  • Senior and Executive Management
  • Contractors and Subcontractors
  • Distributors
  • Consultants

  • Introduction and Agenda Review
  • Medical Device Single Audit Program (MDSAP): Overview, History, Audit Process and Report
  • U.S. FDA – Overview of Medical Device Regulations and Regulatory Processes throughout the Product Life Cycle
    • Device Classification, Licensing Pathways, Human Factors and Usability Studies, Medical Device GMP, Inspection Process, Device Labeling, Combination Products, License Holder Responsibilities
    • (NOTE: Each country session will follow a similar format to the information above)
  • Canada – Overview of Health Canada Medical Device Regulations and Regulatory Processes throughout the Product Life Cycle
  • Brazil  - Overview of ANVISA Medical Device Regulations and Regulatory Processes throughout the Product Life Cycle
  • Australia - Overview of TGA Medical Device Regulations and Regulatory Processes throughout the Product Life Cycle
  • Japan - Overview of PMDA Medical Device Regulations and Regulatory Processes throughout the Product Life Cycle
  • Working Effectively with In-Country Regulatory Agencies
  • Q&A Session

Speaker Profile
For the past 9 years, Bob has been President of RJR Consulting, Inc. The company assists the pharmaceutical, medical device and biotech industries in understanding and complying with International Regulations affecting compliance, new product development, manufacturing and quality assurance. RJR has offices in Columbus, OH, Washington, DC, Brussels, Belgium with exclusive affiliates across Asia and Latin America. Bob has 28 years of past industry experience as a CMC specialist, R&D Director and Global Director of Regulatory Affairs for Merion Merrill Dow pharmaceuticals and Cordis-Dow medical devices. He has a BS / MS degree in Chemistry.

Sign Up for Our Newsletter